Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
13.50
Oct 14 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Oct 13, 4:50 PMTrex Bio closes Nasdaq IPO, raising approximately $116.7 million from 8,333,334 shares at $14.00 per share
Index
-
Market Cap
370.52M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Oct 09, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
54.18%
Insider Trans
0.63%
Inst Own
4.58%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-2.05%
SMA50
-2.05%
SMA200
-2.05%
Trades
Shs Outstand
27.45M
Shs Float
12.58M
52W High
15.50 -12.90%
52W Low
13.21 2.20%
Volatility
- -
ATR (14)
1.01
RSI (14)
-
Beta
-
Rel Volume
0.00
Avg Volume
493.13K
Volume
0
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
0.00%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
13.50
Price
13.50
Change %
0.00%
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Jr.Marion Johnston Erwin
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SVLSF VI, LLC10% OwnerOct 08 '26Buy14.0092,8571,299,998214,869Oct 13 04:30 PM